Bell Investment Advisors’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16
Closed -$1.59K 1909
2026
Q1
$1.59K Hold
16
﹤0.01% 1402
2025
Q4
$1.95K Buy
16
+4
+33% +$502 ﹤0.01% 1365
2025
Q3
$1.35K Hold
12
﹤0.01% 1468
2025
Q2
$1.61K Buy
12
+5
+71% +$549 ﹤0.01% 1433
2025
Q1
$471 Hold
7
﹤0.01% 1777
2024
Q4
$437 Sell
7
-11
-61% -$1.02K ﹤0.01% 1816
2024
Q3
$2.83K Hold
18
﹤0.01% 1210
2024
Q2
$2.71K Hold
18
﹤0.01% 1230
2024
Q1
$1.33K Buy
18
+6
+50% +$495 ﹤0.01% 1506
2023
Q4
$948 Sell
12
-5
-29% -$302 ﹤0.01% 1612
2023
Q3
$931 Buy
17
+5
+42% +$360 ﹤0.01% 1600
2023
Q2
$1.01K Hold
12
﹤0.01% 1601
2023
Q1
$909 Hold
12
﹤0.01% 1612
2022
Q4
$741 Hold
12
﹤0.01% 1664
2022
Q3
$1K Buy
+12
New +$522 ﹤0.01% 1596

Other funds holding TMDX

Bell Investment Advisors's TMDX Position: Q2 2026 in Review

Bell Investment Advisors sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 16 shares — an estimated $1.59K sold.

Bell Investment Advisors first reported a position in TMDX in Q3 2022 and held it in 15 quarters. The position peaked at $2.83K in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Bell Investment Advisors reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Bell Investment Advisors sold 16 Transmedics shares in Q2 2026, an estimated $1.59K.
  • Bell Investment Advisors first reported a position in Transmedics in Q3 2022 and held it in 15 quarters.
  • Bell Investment Advisors's Transmedics position peaked at $2.83K in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.